Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Danaher Corporation — Beckman Coulter

Tracked across 3 events · 18 articles · First seen Apr 13, 2026 · Last active Aug 20, 2026

Sentiment
60
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Tech
Impact: Danaher Corporation — Beckman Coulter, a subsidiary of Danaher Corporation, received CE 2797 mark for its Access MeMed BV assay, enabling broad availability of the test in Europe. This development is expected to enhance its market position in diagnostics.
Apr 13, 2026 · 6 articles
1 50
Business
Multiple market research reports project significant growth in the global hematology analyzers and reagents market over the next several years. MarketsandMarkets forecasts growth from USD 7.57 billion in 2026 to USD 10.33 billion by 2031,…
Impact: Subsidiary of Danaher; key player in analyzers.
Jul 08, 2026 · 6 articles
4 60
Business
Impact: Danaher Corporation — Beckman Coulter is among the prominent players driving innovation and competition in the chemiluminescence immunoassay analyzer market.
Jun 05, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Danaher Corporation — Beckman Coulter live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.